Currently, out of the existing stock ratings of Elliot Wilbur - 19 which are a Hold (13.38%), 122 which are a Buy (85.92%), 1 which are a Sell (0.7%)

Elliot Wilbur

Work Performance Price Targets & Ratings Chart

Analyst Elliot Wilbur works at RAYMOND JAMES and is covering the Healthcare sector with 225 price targets and ratings displayed on 24 stocks. Previously, Elliot Wilbur worked at NEEDHAM.

Elliot Wilbur's average stock forecast success ratio is 40.63% with an average time for price targets to be met of 120.88 days.

Most recent stock forecast was given on SLGL, SolGel Technologies Ltd at 11-Aug-2023.

Wall Street Analyst Elliot Wilbur

Analyst best performing recommendations are on AMRX (AMNEAL PHARMACEUTICALS).
The best stock recommendation documented was for AMRX (AMNEAL PHARMACEUTICALS) at 11/7/2019. The price target of $4 was fulfilled within 26 days with a profit of $1.35 (50.94%) receiving and performance score of 19.59.

Average potential price target upside

of $41.43 (29.71%) on AGN.
of $23 (14.86%) on ZTS (ZOETIS).
of $13.96 (42.28%) on ANIP (ANI PHARMACEUTICALS).

ADMP Adamis Pharmaceuticals AGN AKRX ANIP ANI Pharmaceuticals ATRS Antares Pharma FLXN Flexion Therapeutics MNK MYL PLXP PRGO Perrigo Company plc PTX SGNT SLGL SolGel Technologies Ltd TEVA Teva Pharmaceutical Industries ADMA ADMA Biologics AMRX Amneal Pharmaceuticals CVET Covetrus PETQ PetIQ PYPD VTRS ZTS Zoetis AERI Aerie Pharmaceuticals AMPH Amphastar Pharmaceuticals OGN

Show more stocks

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Jason Mccarthy (MAXIM GROUP)